A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can also be used in intravaginal devices.
Gestrinone has been studied across 12 research domains including 🧬 Hormones, 🔬 Oncology, ♀♂ Sexual Health, 💊 Pain, 💪 Strength & Power. The primary research focus is 🧬 Hormones with 37% of studies addressing this area.
The following compounds share molecular targets with Gestrinone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Gestrinone is generated deterministically from 221 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.